Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.13
+0.01000.02%
Pre-market: 49.731.60+3.32%06:01 EDT
Volume:2.28M
Turnover:109.61M
Market Cap:97.35B
PE:15.39
High:48.80
Open:48.70
Low:47.85
Close:48.12
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.92
T/O Rate:0.12%
Dividend:1.83
Dividend Rate:3.81%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.09
PE(LYR):12.88

Loading ...

GSK Q2 Core Earnings, Sales Rise; Reaffirms 2026 Guidance

MT Newswires Live
·
Jul 28

GSK reports Q2 core EPS 50.5p, up 9% at CER

TIPRANKS
·
Jul 28

Earnings Flash (GSK) GSK Posts Q2 Revenue of 8.41B Pounds ($11.17B), vs. FactSet Est of 8.28B Pounds

MT Newswires Live
·
Jul 28

Earnings Flash (GSK) GSK Posts Q2 Core EPS 50.5 Pence, vs. FactSet Est of $46.47 Pence

MT Newswires Live
·
Jul 28

Stock Track | GSK Soars 5% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Data

Stock Track
·
Jul 28

GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate

Benzinga Earnings
·
Jul 28

Sweeping job cuts at GSK to fund £400m Cambridge campus

cityam
·
Jul 28

GSK’s partner posts positive osteosarcoma data for B7-H3 drug, bolstering oncology push

TIPRANKS
·
Jul 28

GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank

TIPRANKS
·
Jul 28

GSK’s ViiV Healthcare presents data from Phase IIIb VOGUE study

TIPRANKS
·
Jul 28

GSK Climbs Monday, Outperforms Market

Dow Jones
·
Jul 28

GSK Strategy Update in Focus

Dow Jones
·
Jul 27

Citi Initiates a Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 25

J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 24

GSK Canada Wins Approval for Prefilled Shingrix Syringe

MT Newswires Live
·
Jul 24

GSK Plc Expected to Post Earnings of $1.24 a Share - Earnings Preview

Reuters
·
Jul 24

Sector Update: Healthcare Stocks Softer Late Afternoon

MT Newswires Live
·
Jul 23

GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers

Dow Jones
·
Jul 23

Earning Preview: GlaxoSmithKline PLC Q2 revenue is expected to increase by 3.77%, and institutional views are bullish

Earnings Agent
·
Jul 22

GSK’s New Malaria Candidate Advances With Key Drug-Interaction Study

TIPRANKS
·
Jul 22